Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Rig-ging an exit

Rigontec takeout gives Wellington quick exit, momentum into new fund

September 8, 2017 6:33 PM UTC

Wellington Partners’ quick exit from Rigontec GmbH will not only be one of the firm’s best returns from its current fund, but could bolster its fund-raising efforts for a third life sciences fund.

On Sept. 6, Merck & Co. Inc. (NYSE:MRK) announced it will acquire Rigontec for €115 million ($136.8 million) up front and up to €349 million ($415.2 million) in milestones. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Rigontec GmbH